Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 40,000 shares at $19.75 ($790K) on 2012-03-16, disclosed to the SEC on 2012-03-20.
Scheduled sale ($790k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.75 | 2,300 | $45K | 5.8% |
| 2 | $19.75 | 37,700 | $745K | 94.3% |
| Total | $19.75 avg | 40,000 | $790K | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |